Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Expenses: 2019-2024

Historic Operating Expenses for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $208.7 million.

  • Praxis Precision Medicines' Operating Expenses rose 37.14% to $78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.6 million, marking a year-over-year increase of 81.48%. This contributed to the annual value of $208.7 million for FY2024, which is 62.02% up from last year.
  • Praxis Precision Medicines' Operating Expenses amounted to $208.7 million in FY2024, which was up 62.02% from $128.8 million recorded in FY2023.
  • Praxis Precision Medicines' Operating Expenses' 5-year high stood at $215.0 million during FY2022, with a 5-year trough of $62.0 million in FY2020.
  • Over the past 3 years, Praxis Precision Medicines' median Operating Expenses value was $208.7 million (recorded in 2024), while the average stood at $184.2 million.
  • Per our database at Business Quant, Praxis Precision Medicines' Operating Expenses spiked by 170.03% in 2021 and then plummeted by 40.08% in 2023.
  • Praxis Precision Medicines' Operating Expenses (Yearly) stood at $62.0 million in 2020, then surged by 170.03% to $167.3 million in 2021, then grew by 28.48% to $215.0 million in 2022, then crashed by 40.08% to $128.8 million in 2023, then spiked by 62.02% to $208.7 million in 2024.